These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37595489)

  • 41. Evaluating the Soft Tissue Sarcoma Paradigm for the Local Management of Extraskeletal Ewing Sarcoma.
    Boyce-Fappiano D; Guadagnolo BA; Ratan R; Wang WL; Wagner MJ; Patel S; Livingston JA; Lin PP; Diao K; Mitra D; Farooqi A; Lazar AJ; Roland CL; Bishop AJ
    Oncologist; 2021 Mar; 26(3):250-260. PubMed ID: 33289298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multilevel en bloc spondylectomy and chest wall excision via a simultaneous anterior and posterior approach for Ewing sarcoma.
    Samartzis D; Marco RA; Benjamin R; Vaporciyan A; Rhines LD
    Spine (Phila Pa 1976); 2005 Apr; 30(7):831-7. PubMed ID: 15803089
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study.
    Ahrens S; Hoffmann C; Jabar S; Braun-Munzinger G; Paulussen M; Dunst J; Rübe C; Winkelmann W; Heinecke A; Göbel U; Winkler K; Harms D; Treuner J; Jürgens H
    Med Pediatr Oncol; 1999 Mar; 32(3):186-95. PubMed ID: 10064186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of Local Control Outcomes and Clinical Prognostic Factors in Localized Pelvic Ewing Sarcoma Patients Treated With Radiation Therapy: A Report From the Children's Oncology Group.
    Ahmed SK; Witten BG; Harmsen WS; Rose PS; Krailo M; Marcus KJ; Randall RL; DuBois SG; Janeway KA; Womer RB; Grier HE; Gorlick RG; Laack NNI
    Int J Radiat Oncol Biol Phys; 2023 Feb; 115(2):337-346. PubMed ID: 36302496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment and survival of osteosarcoma and Ewing sarcoma of the skull: a SEER database analysis.
    Martin E; Senders JT; Ter Wengel PV; Smith TR; Broekman MLD
    Acta Neurochir (Wien); 2019 Feb; 161(2):317-325. PubMed ID: 30578430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of locus of care on outcomes in adolescents and young adults with osteosarcoma and Ewing sarcoma treated at pediatric versus adult cancer centers: An IMPACT cohort study.
    Mortazavi M; Baxter NN; Gupta S; Gupta AA; Lau C; Nagamuthu C; Nathan PC
    Pediatr Blood Cancer; 2022 Apr; 69(4):e29458. PubMed ID: 35029312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A meta-analytic evaluation of the correlation between event-free survival and overall survival in randomized controlled trials of newly diagnosed Ewing sarcoma.
    Tanaka K; Kawano M; Iwasaki T; Itonaga I; Tsumura H
    BMC Cancer; 2020 May; 20(1):379. PubMed ID: 32370741
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience.
    Rosito P; Mancini AF; Rondelli R; Abate ME; Pession A; Bedei L; Bacci G; Picci P; Mercuri M; Ruggieri P; Frezza G; Campanacci M; Paolucci G
    Cancer; 1999 Aug; 86(3):421-8. PubMed ID: 10430250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group.
    Raciborska A; Bilska K; Drabko K; Chaber R; Sobol G; Pogorzała M; Wyrobek E; Połczyńska K; Rogowska E; Rodriguez-Galindo C; Wożniak W
    Pediatr Blood Cancer; 2014 Dec; 61(12):2170-4. PubMed ID: 25163763
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcomes and prognostic factors for Ewing-family tumors of the extremities.
    Biswas B; Rastogi S; Khan SA; Mohanti BK; Sharma DN; Sharma MC; Mridha AR; Bakhshi S
    J Bone Joint Surg Am; 2014 May; 96(10):841-9. PubMed ID: 24875025
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relation of radiological tumor volume response to histological response and outcome in patients with localized Ewing Sarcoma.
    Haveman LM; Ranft A; Vd Berg H; Smets A; Kruseova J; Ladenstein R; Brichard B; Paulussen M; Kuehne T; Juergens H; Klco-Brosius S; Dirksen U; Merks JHM
    Cancer Med; 2019 Mar; 8(3):1086-1094. PubMed ID: 30790456
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic factors in head and neck Ewing sarcoma family of tumors.
    Biswas B; Thakar A; Mohanti BK; Vishnubhatla S; Bakhshi S
    Laryngoscope; 2015 Mar; 125(3):E112-7. PubMed ID: 25345585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.
    Thiel U; Wawer A; von Luettichau I; Bender HU; Blaeschke F; Grunewald TG; Steinborn M; Röper B; Bonig H; Klingebiel T; Bader P; Koscielniak E; Paulussen M; Dirksen U; Juergens H; Kolb HJ; Burdach SE
    Oncotarget; 2016 Oct; 7(43):70959-70968. PubMed ID: 27486822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of radiation in the treatment of non-metastatic osseous Ewing sarcoma.
    Ning MS; Perkins SM; Borinstein SC; Holt GE; Stavas MJ; Shinohara ET
    J Med Imaging Radiat Oncol; 2016 Feb; 60(1):119-28. PubMed ID: 26439449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of local treatment modality on overall- and disease-specific survival for nonmetastatic pelvic and sacral Ewing sarcoma.
    Jawad MU; Pollock BH; Zeitlinger LN; O'Donnell EF; Traven SA; Carr-Ascher JR; Alvarez E; Malogolowkin MH; Thorpe SW; Randall RL
    J Surg Oncol; 2022 Sep; 126(3):577-587. PubMed ID: 35585834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Is postoperative radiotherapy necessary in localised standard-risk Ewing sarcoma? : The primary tumor bulk decides upon adjuvant radiotherapy after induction chemotherapy and surgery].
    Adamietz IA
    Strahlenther Onkol; 2017 Jan; 193(1):89-90. PubMed ID: 27900390
    [No Abstract]   [Full Text] [Related]  

  • 57. Survival is influenced by approaches to local treatment of Ewing sarcoma within an international randomised controlled trial: analysis of EICESS-92.
    Whelan J; Hackshaw A; McTiernan A; Grimer R; Spooner D; Bate J; Ranft A; Paulussen M; Juergens H; Craft A; Lewis I
    Clin Sarcoma Res; 2018; 8():6. PubMed ID: 29610659
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Local therapy in non-metastatic primary Ewing sarcoma of the mandible and maxilla in children.
    Qureshi SS; Bhagat M; Laskar S; Kembhavi S; Vora T; Ramadwar M; Chinnaswamy G; Prasad M; Khanna N; Shah S; Talole S
    Int J Oral Maxillofac Surg; 2016 Aug; 45(8):938-44. PubMed ID: 27026058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ewing's sarcoma and primitive neuroectodermal tumor of hand and forearm. Experience of the Cooperative Ewing's Sarcoma Study Group.
    Daecke W; Ahrens S; Juergens H; Martini AK; Ewerbeck V; Kotz R; Winkelmann W; Bernd L
    J Cancer Res Clin Oncol; 2005 Apr; 131(4):219-25. PubMed ID: 15614525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Zoledronic Acid Add-on Therapy for Standard-Risk Ewing Sarcoma Patients in the Ewing 2008R1 Trial.
    Koch R; Haveman L; Ladenstein R; Brichard B; Jürgens H; Cyprova S; van den Berg H; Hassenpflug W; Raciborska A; Ek T; Baumhoer D; Egerer G; Kager L; Renard M; Hauser P; Burdach S; Bovee JVMG; Hong AM; Reichardt P; Kruseova J; Streitbürger A; Kühne T; Kessler T; Bernkopf M; Butterfaß-Bahloul T; Dhooge C; Bauer S; Kiss J; Paulussen M; Bonar F; Ranft A; Timmermann B; Rascon J; Vieth V; Kanerva J; Faldum A; Hartmann W; Hjorth L; Bhadri VA; Metzler M; Gelderblom H; Dirksen U
    Clin Cancer Res; 2023 Dec; 29(24):5057-5068. PubMed ID: 37843857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.